HUMAN ISLET RESEARCH NETWORK MISSION
To better understand how human beta cells are lost in Type 1 Diabetes and to find innovative strategies to protect or replace functional beta cell mass in diabetic patients.
Our Research
Supporting Collaborative Research since 2014
The Human Islet Research Network (HIRN) was established in 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.
Research Resources
Latest News
NIH NIDDK New Investigator Gateway Award Recipients (Nov 2023)
Congratulations to the November 2023 Recipients of the NIH NIDDK New Investigator Gateway Awards Congratulations to these three investigators on joining HIRN via the NIH NIDDK Gateway Award Initiative. This…
Read MoreHIRN 2023 Trainee Scholarship Recipients
The following trainees are recipients of the HIRN 2023 Annual Investigator Meeting! Award recipients were selected solely based on evaluations by HIRN members on their presentations (oral or poster) at…
Read MoreHIRN Webinar: “Synthetic Biology and Type 1 Diabetes: New Approaches to Protect and Construct Islets”
Thursday, August 24, 2023 (1:00 pm Eastern / 10:00 am Pacific) Register HERE Topics discussed: Immune destruction of islets in T1D requires therapeutic strategies to protect and/or replace islets Expanding…
Read MoreConsortia
Independent Research Initiatives
HIRN-OPP
Opportunity Pool Projects
The Human Islet Research Network (HIRN) was established In 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.
